Yilong Ma

Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects.

Pallidal stimulation for parkinsonism: improved brain activation during sequence learning.

Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression.

Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.

Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression.

Primary dystonia: is abnormal functional brain architecture linked to genotype?

Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects.

Evolving metabolic changes during the first postoperative year after subthalamotomy.

Serotonin modulation of cerebral glucose metabolism in normal aging.

Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics.

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.

The metabolic topography of posthypoxic myoclonus.

Effects of serotonin transporter promoter polymorphisms on serotonin function.

The metabolic pathology of dopa-responsive dystonia.

Preclinical Huntington's disease: compensatory brain responses during learning.

Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease.

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism.

Network modulation in the treatment of Parkinson's disease.

Functional imaging of cerebral blood flow and glucose metabolism in Parkinson's disease and Huntington's disease.

Changes in network activity with the progression of Parkinson's disease.

Arctic Peoples and Beyond: research opportunities in neuroscience and behaviour.

New strategies for automated differential diagnosis of degenerative brain disorders.

Abnormal metabolic networks in atypical parkinsonism.

Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography.

Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

Simultaneous measurement of brain tissue oxygen partial pressure, temperature, and global oxygen consumption during hibernation, arousal, and euthermy in non-sedated and non-anesthetized Arctic ground squirrels.

Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.

Abnormal regional brain function in Parkinson's disease: truth or fiction?

Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: a randomized, placebo-controlled study.

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

The functional neuroanatomy of geriatric depression.

Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.

Serotonin modulation of cerebral glucose metabolism in depressed older adults.

Modulation of metabolic brain function by bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease.

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.

Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI.

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.

Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.

The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.

Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.

Dopamine cell transplantation in Parkinson's disease: challenge and perspective.

Deconstruction of the α4β2 nicotinic acetylcholine receptor positive allosteric modulator desformylflustrabromine.

Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism.

Novel cell-penetrating peptides based on α-aminoxy acids.

Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging.

Correlation of laparoscopic experience with differential functional brain activation: a positron emission tomography study with oxygen 15-labeled water.

Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.

Serotonin modulation of cerebral glucose metabolism: sex and age effects.

Abnormal network topographies and changes in global activity: absence of a causal relationship.

Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.

Parkinson's disease: increased motor network activity in the absence of movement.

Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.

Parkinson's disease cognitive network correlates with caudate dopamine.

Characterization of disease-related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners.